Lithium Carbonate Tablet, Film Coated, Extended Release
Product Images NDC 68462-223

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 68462-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lbl300mg100s

Lbl300mg100s
This is a prescription medication with the active ingredient Lithium Carbonate. It is in the form of extended-release tablets, and there are 100 tablets in the package. The manufacturer is Glenmark. No prescribing information is provided.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.